Saturday, 27 April 2024

 

 

LATEST NEWS Mann's roar in Majha!, starts AAP's election campaign in Gurdaspur for Shery Kalsi Mann in Amritsar -When the people of Majha make up their minds, they do not sway, this time they have decided to make AAP win Congress will provide 50 percent reservation to women in jobs: Lamba Haryana CEO takes first-of-its-kind initiative, State Voters to receive Wedding-Style Invitations for General Elections Wheat procurement gains pace as agencies procure 334283.4 MT grains Governor Shiv Pratap Shukla presents Road Safety Awards From Siliguri to a Chai Empire: How a Women Entrepreneur Brew a Successful Tea selling brand CHAIOM Science Fest organised at Rayat Bahra University Detaining the colonizer is a highly condemnable act - Gurjit Singh Aujla AIMS Mohali Observes DNA Day Vigilance Bureau Arrests Patwari Accepting Rs 10,000 Bribe For Mutation Of Land Vigilance Bureau Nabs Senior Assistant For Taking Rs 20,000 Bribe Vigilance Bureau Nabs Reader Of Sho Nri Police Station Taking Rs 20,000 Bribe SANY Heavy Industry India Pvt Ltd Expands Presence with Grand Opening of Raghunath Machinery HO in Rayagada, Odisha Ideathon 2K24 held at CGC Jhanjeri, 160 teams from various colleges participated Retailers Discuss Ways to Stay Ahead of the Curve at the RAI Hyderabad Retail Summit 2024 Bobby Deol Drives the Badass Seltos Hyundai Motor Group Executive Chair Euisun Chung Visits India to Underline Mid-to long-term Mobility Strategic Commitments Rupnagar police arrest accomplice of attackers involved in murder of VHP leader Vikas Prabhakar Complete exercise of identifying critical polling stations within this week : Sakshi Sawhney The impact of the Deputy Commissioner Dr. Senu Duggal strictness, a record jump in lifting in two days

 

Pfizer Covid jab's side effects in 12-15 year olds mild: Study

Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Oxygen supply, Liquid Medical Oxygen, Oximeter
Listen to this article

Web Admin

Web Admin

5 Dariya News

London , 27 Aug 2021

The side effects of the Pfizer-BioNTech jab against Covid-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a study.While the study numbers are small, the data are representative of those teenagers most likely to benefit from the vaccination, and should offer reassurance to parents and clinicians, said researchers from the Bristol Royal Hospital for Children in the UK.In the study, to be published in the Archives of Disease in Childhood, the researchers asked the parents of 27 children, aged between 12 and 15, to record any side effects of subsequent Covid-19 vaccinations for each child.The children had various neurological conditions, including muscular dystrophy and cerebral palsy, plus a range of coexisting medical conditions, such as epilepsy, congenital heart defects, and immune deficiency, for which they were receiving drug treatment of various kinds.The reported side effects were all mild to moderate, with the exception of one child who experienced severe fatigue and discomfort, combined with increased agitation. 

One family also reported that seizure type changed to clusters, although this had resolved a week later.In all, there were eight 'events' in six children after the first dose, all of which resolved within 72 hours: mild rash; headache; diarrhoea; presumed sore throat; neck pain; difficulty sleeping; and low blood glucose.After the second dose, eight additional events occurred in five children: diarrhoea; vomiting; armpit swelling; and blisters around the mouth.Paracetamol use after the first dose was high and fever was more common than reported in studies of adults. But all recorded side effects cleared up within a week.The UK's independent vaccine advisory group, the Joint Committee on Vaccination and Immunisation (JCVI), advised that children aged 12 and over with severe neurological disabilities, who tend to get recurrent respiratory infections and have complex care needs, should be offered the Covid-19 jab.The only Covid jab currently authorised in the UK for under-18s is the Pfizer-BioNTech vaccine.Countries, including the US, Canada and France, have already rolled out vaccines for people aged 12 years old and above.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Oxygen supply , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD